Home › Research › Cognitive tests and assessment
A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer's Disease
Lozano AM, Fosdick L, Chakravarty MM, Leoutsakos JM, Munro C, Oh E, Drake KE, Lyman CH et al.. Journal of Alzheimer's disease : JAD, 2016-09-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Background Deep brain stimulation (DBS) is used to modulate the activity of dysfunctional brain circuits. The safety and efficacy of DBS in dementia is unknown. Objective To assess DBS of memory circuits as a treatment for patients with mild Alzheimer's disease (AD).
What this study adds
Evidence grade: High
The record lists 42 participants. In a randomized, double-blind trial, 42 patients with mild Alzheimer's disease received active or sham deep brain stimulation directed at the fornix, with cognitive function and cerebral glucose metabolism measured up to 12 months after implantation. This was a Phase II study testing safety and efficacy of a treatment, and it does not report a cure or prevention.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Lozano, A. M., Fosdick, L., Chakravarty, M. M., Leoutsakos, J. M., Munro, C., Oh, E., et al. (2016). A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer's Disease. Journal of Alzheimer's disease : JAD. https://doi.org/10.3233/jad-160017
Vancouver
Lozano AM, Fosdick L, Chakravarty MM, Leoutsakos JM, Munro C, Oh E, et al. A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer's Disease. Journal of Alzheimer's disease : JAD. 2016. doi:10.3233/jad-160017. PMID: 27567810.
BibTeX
@article{lozano2016-27567810,
author = {Lozano, A. M. and Fosdick, L. and Chakravarty, M. M. and Leoutsakos, J. M. and Munro, C. and Oh, E. and Drake, K. E. and Lyman, C. H. and others},
title = {{A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer's Disease}},
journal = {Journal of Alzheimer's disease : JAD},
year = {2016},
doi = {10.3233/jad-160017},
pmid = {27567810},
url = {https://doi.org/10.3233/jad-160017}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- The safety and efficacy of DBS in dementia is unknown.
- Objective To assess DBS of memory circuits as a treatment for patients with mild Alzheimer's disease (AD).
- Methods We evaluated active "on" versus sham "off" bilateral DBS directed at the fornix-a major fiber bundle in the brain's memory circuit-in a randomized, double-blind trial (ClinicalTrials.gov NCT01608061) in 42 patients with mild AD.
- We measured cognitive function and cerebral glucose metabolism up to 12 months post-implantation.
Why it matters
In a randomized, double-blind trial, 42 patients with mild Alzheimer's disease received active or sham deep brain stimulation directed at the fornix, with cognitive function and cerebral glucose metabolism measured up to 12 months after implantation. This was a Phase II study testing safety and efficacy of a treatment, and it does not report a cure or prevention.
Study details
- Study designpost-hoc analysis
- Participants42
- Evidence strengthHigh
How this study scored 71/100
Published in a peer-reviewed journal, and it is a mid-stage phase 2 trial. Scored zero for effect reported because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of Alzheimer's disease : JAD) |
| Journal's citation record | 2 / 4 | Journal of Alzheimer s Disease: journal h-index 218 (OpenAlex, 2026-10-29) |
| Study design | 8 / 12 | A mid-stage phase 2 trial (from PubMed type “Clinical Trial, Phase II”) |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2016 — within 20 year(s) of the newest study here |
| Sample size | 1 / 4 | 42 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 2 / 2 | Randomized and blinded or placebo-controlled (as stated in the record) |
| Times cited | 6 / 7 | Cited 330 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 27.5 citations a year over 12 year(s) since 2016 |
| Impact for its field and year | 5 / 6 | Cited 22.8× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 7 other studies in this library |
| Still being cited | 3 / 4 | Cited 78 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Gwenn S. Smith: h-index 54 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | Johns Hopkins University: institution h-index 2,306 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 15 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 27567810) |
| Free to read | 2 / 2 | Free to read |
| Total | 71 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.3233/jad-160017
- PubMed: 27567810
- Original source →
- Free full text: Journal of Alzheimer s Disease →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
7 studies in the alzhub library list this one in their references.
Related studies in Cognitive tests and assessment from nearby years
Also tagged “trial”
783 studies in the library carry the topic tag “trial”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 783 tagged studies.